Lactase Market Size and Share
Lactase Market Analysis by Mordor Intelligence
The lactase market size was USD 250.56 million in 2025 and is forecast to reach USD 268.25 million in 2026 and USD 380.30 million by 2031, growing at a CAGR of 7.23% during 2026-2031. Dairy processors are using lactase to remove lactose and develop natural sweetness in the same production step, and this is relevant when processors plan sourcing, production, and product placement. This supports reformulation of milk, yogurt, ice cream, and related products with less added sugar, remaining important across formulation, plant operations, and customer delivery. Demand is also moving beyond premium lactose-free offerings as private-label and mid-tier dairy brands add such products to their regular development programs, with the commercial effect depending on reliable execution across the dairy value chain. Regulatory review, milk supply conditions, and lower-priced enzyme competition will continue to shape supplier strategies in the lactase market, while processors weigh product quality, operating needs, distribution conditions, and the expectations of their target consumers, across the commercial and operating realities of dairy production, with implications for enzyme selection, process validation, supply planning, and the ability to deliver familiar dairy products to consumers consistently.
Key Report Takeaways
- By form, liquid lactase held 44.23% of the Lactase market share in 2025, while dry/powder lactase is forecast to grow at a 7.48% CAGR through 2031.
- By source, yeast-derived lactase held 56.17% of the Lactase market share in 2025, while fungal lactase is forecast to grow at a 7.66% CAGR through 2031.
- By application, dairy processing accounted for 62.04% of the Lactase market size in 2025 and is forecast to grow at an 8.64% CAGR through 2031.
- By geography, North America held 34.05% of the global Lactase market in 2025, while Asia-Pacific is forecast to grow at a 7.89% CAGR through 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.
Market Trends and Insights
Drivers Impact Analysis of Lactase Market*
| Drivers | (~) % Impact on CAGR Forecasts | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Growing Prevalence of Lactose Intolerance | +1.8% | Global, highest in Asia-Pacific, Latin America, and Sub-Saharan Africa | Long term (≥ 4 years) |
| Enzyme-Immobilization Technologies Reducing Production Costs | +0.8% | Global, strongest technology adoption in Europe and North America | Long term (≥ 4 years) |
| Rising Demand For Clean-Label Enzymes | +1.2% | Europe and North America, expanding to Japan and South Korea | Medium term (2-4 years) |
| Low-Sugar Positioning Enabled By Lactase | +1.0% | Global, most commercially advanced in North America and Northern Europe | Medium term (2-4 years) |
| Surge in Lactose-Free Product Launches | +0.8% | North America and Europe; spreading to Asia-Pacific | Medium term (2–4 years) |
| Micro-Channel Bioreactors For On-Site Use | +0.4% | Industrial hubs in North America, Europe, East Asia | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Growing Prevalence of Lactose Intolerance
The lactase market has a broad demand base because lactose malabsorption affects a large share of the global population, influencing both day-to-day plant management and longer-term product planning. The U.S. National Library of Medicine states that lactose intolerance is common and occurs when the small intestine does not make enough lactase, reinforcing its relevance to commercial dairy formulation and production planning and affecting how suppliers support dairy customers with technical and commercial guidance. Nearly 70% of adults globally have genetic lactase non-persistence, particularly in Asia, Africa, and Latin America, making them unable to digest conventional dairy products without discomfort, according to the MedlinePlus data [1]. Better diagnostic access can shift consumers from avoiding dairy to choosing lactose-reduced dairy products, and this is relevant when processors plan sourcing, production, and product placement. This creates an opportunity for processors to retain dairy consumption among people who experience symptoms after consuming conventional milk products, remaining important across formulation, plant operations, and customer delivery. The lactase market therefore benefits when health guidance, retail availability, and consumer income support lactose-reduced choices.
Enzyme-Immobilization Technologies Reducing Production Costs
Immobilized lactase can lower the cost of lactose hydrolysis because the enzyme can be used across more than one processing cycle, with the commercial effect depending on reliable execution across the dairy value chain. A 2025 Scientific Reports study found that an immobilized lactase system retained activity through at least 8 reuse cycles and remained stable for 90 days at 4°C, while also shaping choices made by procurement and product development teams. The study also reported 50% lactose hydrolysis within the first hour in 3% fat milk, especially where product consistency and operating discipline are essential. Separate 2025 research reported 69% activity retention after 12 sequential reuse cycles for recombinant BgaC lactase immobilized in alginate-gelatin beads, reinforcing its relevance to commercial dairy formulation and production planning, influencing both day-to-day plant management and longer-term product planning. These results support the case for reuse-based systems in dairy plants that can operate fixed-bed or comparable processing equipment, affecting how suppliers support dairy customers with technical and commercial guidance. The lactase market may gain new mid-scale users as these systems move from laboratory studies into validated production settings.
Rising Demand for Clean-Label Enzymes
Dairy processors are reviewing enzyme sourcing more closely when they develop products with simple ingredient declarations. Yeast-derived lactase remains useful in this setting because it has a long record of food use and operates at the pH range of fresh milk, which is relevant when processors plan sourcing, production, and product placement. The European Union requires authorization of food enzymes before they are placed on the market, which makes complete safety documentation important for suppliers, reinforcing its relevance to commercial dairy formulation and production planning, and remaining important across formulation, plant operations, and customer delivery. This requirement can favor established producers with established regulatory documentation, with the commercial effect depending on reliable execution across the dairy value chain.
Low-Sugar Positioning Enabled by Lactase
Lactase converts lactose into simpler sugars that can increase perceived sweetness in dairy products, especially where product consistency and operating discipline are essential. This can help product developers reduce added sugar while maintaining a familiar taste profile, influencing both day-to-day plant management and longer-term product planning. dsm-firmenich has described the use of lactase in a zero-added-sugar high-protein yogurt development initiative, reinforcing its relevance to commercial dairy formulation and production planning and affecting how suppliers support dairy customers with technical and commercial guidance. The approach allows a processor to address digestibility and sugar-reduction goals through the same processing input, which matters as product teams align consumer needs with routine manufacturing decisions.
Restraints Impact Analysis of Lactase Market*
| Restraints | (~) % Impact on CAGR Forecasts | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Volatility In Dairy Supply Affecting Enzyme off-Take | -0.9% | Global, acute in South Asia and parts of Latin America | Short term (≤ 2 years) |
| Regulatory Hurdles For GMO-Derived Recombinant Lactase | -0.7% | EU and Asia-Pacific, moderate in North America | Long term (≥ 4 years) |
| Allergen-Labeling Complexities in Multi-Enzyme Blends | -0.2% | North America and Europe, expanding globally | Medium term (2-4 years) |
| Price Pressure from Chinese Low-Cost Enzyme Producers | -0.5% | Global, with highest impact in price-sensitive markets | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Volatility in Dairy Supply Affecting Enzyme off-Take
Lactase use is linked directly to the volume of milk processed in dairy facilities, remaining important across formulation, plant operations, and customer delivery. When processors reduce milk intake, lactase procurement can fall because dosage is tied to processing throughput, with the commercial effect depending on reliable execution across the dairy value chain. This exposure is relevant in places affected by weather variability, herd reductions, or weak farm-gate prices, while also shaping choices made by procurement and product development teams. Multi-year supply agreements do not fully protect enzyme suppliers against lower production volumes, especially where product consistency and operating discipline are essential. Liquid enzyme inventory can also add refrigerated storage costs when demand is delayed, influencing both day-to-day plant management and longer-term product planning.
Regulatory Hurdles for GMO-Derived Recombinant Lactase
Rules for genetically modified food enzymes differ across jurisdictions and can delay commercial use of recombinant lactase, affecting how suppliers support dairy customers with technical and commercial guidance. In the European Union, food enzymes require authorization under Regulation (EC) No 1332/2008 before they may be marketed, reinforcing their relevance to commercial dairy formulation and production planning. The authorization process requires a scientific assessment and supporting dossier, and this is relevant when processors plan sourcing, production, and product placement. This can delay the introduction of variants designed for cold processing, higher temperature use, or reduced galactose inhibition, remaining important across formulation, plant operations, and customer delivery.
*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.
Lactase Market Segment Analysis
By Form:
Liquid Retains Industrial Use While Dry/Powder Benefits From LogisticsLiquid lactase held 44.23% of the form segment in 2025, while also shaping choices made by procurement and product development teams. It remains widely used in high-throughput plants where continuous-flow dosing and cleaning-in-place compatibility are important, especially where product consistency and operating discipline are essential. Precise volumetric control also supports consistent hydrolysis across large production runs, influencing both day-to-day plant management and longer-term product planning. Liquid preparations fit established operating procedures at many large dairy facilities, affecting how suppliers support dairy customers with technical and commercial guidance.
Dry/powder lactase is forecast to expand at a 7.48% CAGR during 2026-2031. It offers ambient-temperature storage and reduces the cost and complexity of refrigerated shipping, and this is relevant when processors plan sourcing, production, and product placement. These features are relevant for smaller processors and co-manufacturers that do not have inline injection equipment, remaining important across formulation, plant operations, and customer delivery. The form also supports batch dosing for new lactose-free product programs, with the commercial effect depending on reliable execution across the dairy value chain.
By Source:
Yeast Leads While Fungal Options Serve Demanding Processing ConditionsYeast-derived lactase held 56.17% of the source segment in 2025, while also shaping choices made by procurement and product development teams. Its long history of food use, neutral-pH performance, and established production infrastructure support its role in fresh milk processing, especially where product consistency and operating discipline are essential. Kluyveromyces lactis is a key commercial source for enzyme products used in dairy applications, influencing both day-to-day plant management and longer-term product planning. The format also supports clean-label positioning in food and dietary supplement products, affecting how suppliers support dairy customers with technical and commercial guidance.
Fungal lactase is forecast to grow at a 7.66% CAGR through 2031. Aspergillus oryzae and Aspergillus niger are relevant where processors need activity in more acidic conditions or at higher temperatures, and this is relevant when processors plan sourcing, production, and product placement. This makes fungal variants useful for UHT milk and fermented dairy products, remaining important across formulation, plant operations, and customer delivery. Bacterial-derived products remain a smaller source group but can serve applications that require cold-temperature activity or precise dosing.
By Application:
Dairy Processing Combines the Largest Base With the Fastest GrowthDairy processing accounted for 62.04% of the lactase market size in 2025, while also shaping choices made by procurement and product development teams. It is also forecast to grow at an 8.64% CAGR through 2031, making it both the largest application and the fastest-growing one, especially where product consistency and operating discipline are essential. The application includes milk, yogurt, ice cream, and other dairy products that require lactose hydrolysis, influencing both day-to-day plant management and longer-term product planning. Dairy processors can use lactase to improve digestibility and support sugar-reduction formulations, affecting how suppliers support dairy customers with technical and commercial guidance.
Yogurt is a demanding use case because pH declines during fermentation and enzyme activity must remain reliable as conditions change,. Acid-stable fungal preparations can be more suitable than conventional neutral-pH yeast products in such formulations, and this is relevant when processors plan sourcing, production, and product placement. Dietary supplements and pharmaceuticals form a second application tier that includes tablets, capsules, and chewable products, remaining important across formulation, plant operations, and customer delivery. The others category includes whey permeate processing and specialty nutrition applications, with the commercial effect depending on reliable execution across the dairy value chain.
Geography Analysis
North America held 34.05% of the global lactase market in 2025, while also shaping choices made by procurement and product development teams. Mature lactose-free retail distribution, high dairy consumption, and established enzyme-capable processors support regional demand, especially where product consistency and operating discipline are essential. The United States accounts for much of this activity because lactose-free dairy is available across mainstream retail channels, influencing both day-to-day plant management and longer-term product planning. Private-label programs can extend category access beyond premium branded products, affecting how suppliers support dairy customers with technical and commercial guidance.
Europe is the second-largest regional market, which matters as product teams align consumer needs with routine manufacturing decisions. Germany, France, and the United Kingdom are important demand centers for products supported by clean-label and non-GMO positioning, and this is relevant when processors plan sourcing, production, and product placement. Regulatory documentation under the European food enzyme framework reinforces the value of well-characterized enzyme sources, remaining important across formulation, plant operations, and customer delivery. South America and the Middle East and Africa hold smaller shares of the lactase market, with the commercial effect depending on reliable execution across the dairy value chain.
Asia-Pacific is forecast to grow at a 7.89% CAGR through 2031, while also shaping choices made by procurement and product development teams. The region has a large population with low genetic lactase persistence, which creates a broad potential demand base for lactose-treated dairy, especially where product consistency and operating discipline are essential. The opportunity depends on consumer awareness, organized dairy retail, and reliable access to food-grade enzymes, influencing both day-to-day plant management and longer-term product planning. India and China are important volume opportunities as urban consumers seek dairy products that better suit digestive needs, affecting how suppliers support dairy customers with technical and commercial guidance.
Competitive Landscape
Market Concentration
The lactase market includes Novonesis, dsm-firmenich, and Kerry Group among the companies that set technical and compliance expectations in industrial dairy applications. These companies compete through enzyme research, product consistency, application support, and documentation rather than price alone, and this is relevant when processors plan sourcing, production, and product placement.
Kerry Group opened an expanded biotechnology manufacturing hub in Carrigaline, Ireland, in April 2026, while also shaping choices made by procurement and product development teams. The company states that the site supports more than 200 customers across 80 countries and processes more than 2 million tonnes of milk annually, especially where product consistency and operating discipline are essential. The expansion connects production capacity with biotechnology and dairy application capabilities, influencing both day-to-day plant management and longer-term product planning.
The FDA's GRAS approval of lactase enzyme from Aspergillus oryzae, with a no observed adverse effect level of 2000 mg/kg/day, provides a regulatory framework for new enzyme formulations [2]. New market entrants utilize precision fermentation and synthetic biology to develop enhanced enzyme variants, while established companies maintain their position through regulatory knowledge and strong customer relationships. WIPO published patent WO2026183952 in September 2026 for a Kluyveromyces marxianus strain described for high lactase activity, remaining important across formulation, plant operations, and customer delivery. The competitive position of newer strains will depend on performance, production economics, and regulatory acceptance in each market.
Lactase Industry Leaders
-
Novozymes A/S
-
dsm-firmenich
-
International Flavors and Fragrances Inc.
-
Kerry Group plc
-
Advanced Enzyme Technologies Ltd.
- *Disclaimer: Major Players sorted in no particular order
Lactase Market Companies Covered in this Report
- dsm-firmenich
- Novozymes A/S
- Kerry Group plc
- International Flavors and Fragrances Inc.
- Advanced Enzyme Technologies Ltd.
- Amano Enzyme Inc.
- Merck KGaA (Sigma-Aldrich)
- Infinita Biotech Pvt Ltd
- Gk Biochemical Corporation
- Biocatalysts Ltd.
- SternEnzym GmbH
- Enzyme Development Corp.
- Creative Enzymes
- Bioven Ingredients
- Shriji exbiz Pvt. Ltd.
- Biofermen Private Limited
- AB Enzymes
- Anthem Biosciences
- Optiferm GmbH
- Lactalis Ingredients
Recent Industry Developments in Lactase Market
- April 2026: Kerry Group opened its expanded biotechnology manufacturing facility in Carrigaline, Co. Cork, Ireland, supporting more than 200 customers across 80 countries and processing over 2 million tonnes of milk annually, integrated with Kerry's Biotechnology Centre in Leipzig, Germany.
- November 2024: LactoSens technology enabled fast, accurate, and cost-effective lactose detection across the food and beverage industry. Kerry Group acquired the biosensor technology from Austria-based DirectSense, which continued to manufacture LactoSens under a contract manufacturing agreement, ensuring consistent product quality.
Global Lactase Market Report Scope
The Lactase Market Report is Segmented by Form (Liquid, Dry/Powder, Granular/Immobilized), Source (Yeast, Fungi and Bacteria), Application (Dairy Processing, Dietary Supplements and More), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).
Segmentation Overview
| Liquid |
| Dry/Powder |
| Granular/Immobilise |
| Yeast |
| Fungi |
| Bacteria |
| Dairy Processing | Cheese |
| Yogurt | |
| Ice-Cream | |
| Other Dairy Processing | |
| Dietary Supplements and Pharmaceuticals | |
| Other Applications |
| North America | United States |
| Canada | |
| Mexico | |
| Rest of North America | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Rest of Europe | |
| Asia-Pacific | China |
| India | |
| Japan | |
| Rest of Asia-Pacific | |
| South America | |
| Middle East and Africa |
| Form | Liquid | |
| Dry/Powder | ||
| Granular/Immobilise | ||
| Source | Yeast | |
| Fungi | ||
| Bacteria | ||
| Application | Dairy Processing | Cheese |
| Yogurt | ||
| Ice-Cream | ||
| Other Dairy Processing | ||
| Dietary Supplements and Pharmaceuticals | ||
| Other Applications | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Rest of North America | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| India | ||
| Japan | ||
| Rest of Asia-Pacific | ||
| South America | ||
| Middle East and Africa | ||
Key Questions Answered in the Report
What is the current size of the lactase sector?
The lactase market is valued at USD 250.56 million in 2025 and is forecast to reach USD 380.30 million by 2031 at a 7.23% CAGR.
Which application uses the most lactase?
Dairy processing leads with 62.04% of revenue in 2025 and has the highest forecast growth rate at 8.64% through 2031.
Which lactase form is growing fastest?
Dry/powder lactase is forecast to grow at a 7.48% CAGR through 2031, supported by ambient storage and simpler logistics.
Why is fungal lactase gaining use?
Fungal lactase is forecast to grow at a 7.66% CAGR because it can support UHT and fermented dairy processing across challenging pH and temperature conditions.